The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

Abstract

These results support the EORTC QLQ-C30 as a reliable and valid measure of the quality of life of cancer patients in multicultural clinical research settings. Work is ongoing to examine the performance of the questionnaire among more heterogenous patient samples and in phase II and phase III clinical trials.

Keywords

Quality of life (healthcare)Cronbach's alphaClinical trialConstruct validityMedicineNauseaPhysical therapyReliability (semiconductor)PsychologyPsychometricsClinical psychologyInternal medicineNursing

Affiliated Institutions

Related Publications

Interpreting the significance of changes in health-related quality-of-life scores.

David Osoba , George Rodrigues , James D. Myles +2 more

PURPOSE To determine the significance to patients of changes in health-related quality-of-life (HLQ) scores assessed by the European Organization for Research and Treatment of C...

1998 Journal of Clinical Oncology 2826 citations

Quality of Life in Palliative Cancer Care: Results From a Cluster Randomized Trial

Marit Slaaen , Peter Fayers , Jon Håvard Loge +2 more

PURPOSE: To assess the impact of comprehensive palliative care on patients’ quality of life. The intervention was based on cooperation between a palliative medicine unit and the...

2001 Journal of Clinical Oncology 244 citations

Irinotecan Plus Oxaliplatin and Leucovorin-Modulated Fluorouracil in Advanced Pancreatic Cancer—A Groupe Tumeurs Digestives of the Fédération Nationale des Centres de Lutte Contre le Cancer Study

Thierry Conroy , B Paillot , Éric François +10 more

Purpose To evaluate response rate and toxicity of irinotecan and oxaliplatin plus fluorouracil (FU) and leucovorin (Folfirinox) in advanced pancreatic adenocarcinoma (APA). Pati...

2005 Journal of Clinical Oncology 238 citations

Assessment of Quality of Life in the Supportive Care Setting of the Big Lung Trial in Non–Small-Cell Lung Cancer

Julia Brown , H. Thorpe , Vicky Napp +10 more

Purpose The Big Lung Trial (BLT) was a large, pragmatic trial to evaluate the addition of chemotherapy to primary treatment (ie, surgery, radical radiotherapy, or supportive car...

2005 Journal of Clinical Oncology 83 citations

Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non—Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly Study

Paolo Maione , Francesco Perrone , Ciro Gallo +17 more

Purpose To study the prognostic value for overall survival of baseline assessment of functional status, comorbidity, and quality of life (QoL) in elderly patients with advanced ...

2005 Journal of Clinical Oncology 477 citations

Publication Info

Year: 1993
Type: article
Volume: 85
Issue: 5
Pages: 365-376
Citations: 15215
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

15215

OpenAlex

Cite This

APA Style

                            
                                
                                    N.K. Aaronson, 
                                
                                    Sam H. Ahmedzai, 
                                
                                    Bengt Bergman
                                
                                et al.
                            
                            (1993). 
                            The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology. 
                            JNCI Journal of the National Cancer Institute
                            , 85
                            (5)
                            , 365-376.
                            https://doi.org/10.1093/jnci/85.5.365
                        

Identifiers

DOI: 10.1093/jnci/85.5.365